Endocrinology Advisor1d
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
FPIs offloaded ₹780 billion in Indian equities in January—Here’s where they increased their stake
Despite relentless FII outflows, select Indian stocks saw increased foreign interest in the December ended —here’s where ...
pharmaphorum1d
Sanofi turns the tables on Lilly with biosimilar fast-acting insulin
Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition ... which is available in vial form or as a disposable pen. Sanofi fights back This represents Sanofi's first foray into ...
FDA approves first rapid-acting insulin biosimilar for patients with diabetes
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
Interesting Engineering on MSN2d
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatment
The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...
FDA approves first rapid-acting insulin
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
Medscape4d
A Review of 20 Years' Experience With the Novopen Family of Insulin Injection Devices
NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...
Medscape2d
Insulin Infusion Protocol for Critical Care Units
Insulin solutions must be remixed every 24 hours to maintain potency. Notify the physician if the infusion rate exceeds 16 units/hr or if hypoglycemia has not resolved after 50 mL of 50% dextrose ...
pharmaphorum4d
Capping the cost of insulin: altruistic or strategic?
Novo Nordisk lowered the list price on various insulin products, including pre-filled insulin pens and vials. The company suggested that this would mean patients would pay $25-35 for their insulin.